Skip to content
lifestyle.humane.net
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
NurExone Biologic Inc
NurExone Demonstrates Consistent Anti-Inflammatory Activity Across Three Separate Batches of Exosomes
October 30, 2026
NurExone Demonstrates Scalable Exosome Production, Supporting Its Modular Manufacturing Strategy and Commercial Growth
October 22, 2026
NurExone Advances Optic Nerve Injury Program Toward Larger-Animal Study, Following Positive Preclinical Results
October 9, 2026
NurExone Expands U.S. Engagement Across Four Major Boston Life Sciences Events and Provides Corporate Update
September 18, 2026
NurExone Announces Voting Results of Annual General and Special Meeting of Shareholders and Provides Corporate Update
September 16, 2026
NurExone and NanoPass Technologies Ltd. to Collaborate on Integrated Exosome Delivery Approach for Regenerative Eye and Skin Applications
September 14, 2026
NurExone Biologic Inc. Announces Second Quarter 2026 Financial Results
August 31, 2026
NurExone Biologic Inc. to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference
August 28, 2026
NurExone Announces Annual General and Special Meeting to Consider Share Consolidation in Support of U.S. Capital Markets Strategy
August 21, 2026
NurExone Announces Closing of C$1,066,078 Private Placement
August 20, 2026
1
2
Next Page
→